STXS · AMEX
Stereotaxis, Inc.
$0.91 0.00 (-0.25%)
Company overview
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for interventional laboratories in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through blood vessels and chambers of the heart to treatment sites. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks, and the Stereotaxis Imaging Model S X-ray system, a single-plane full-power system with c-arm, powered table, motorized boom, and high-definition monitors for robotic interventional operating rooms.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Exchange
- AMEX
- Market cap
- $91.2M
- Employees
- 139
- Headquarters
- Saint Louis, MO
- Website
- stereotaxis.com
- CEO
- David Leo Fischel
- Listed
- August 12, 2004
- P/E
- -3.73
- Dividend yield
- 0.00%
Company financials
- Revenue
- $31.2M
- Gross profit
- $16.8M
- Operating income
- -$21.4M
- EBITDA
- -$19.5M
- Net income
- -$21.7M
- EPS
- -$0.24
- Total assets
- $54M
- Total debt
- $5.3M
- Gross margin
- 53.86%
- Net margin
- -69.50%
- Earnings yield
- -26.84%
Showing FY 2025
STXS
1D
AMEX
O0.99H1.00L0.91C0.91-0.06 (-5.98%)Vol329.42K